Nomdedeu et al identified factors associated with excess mortality in a patient with myelodysplasia. These can help to identify a patient who may benefit from more aggressive management. The authors are from multiple hospitals who participate in the Spanish MDS Group.
Patient selection: myelodysplastic syndrome
Excess mortality: mortality rate for patients with MDS versus mortality expected for a person of equivalent demographics
Predictors of excess mortality:
(1) older age
(2) male sex
(3) leukemic transformation
(4) intermediate, high and very high-risk categories (IPSS-R), with some excess with low risk
(5) comorbidities
Improved survival of a patient with myelodysplasia involves addressing multiple factors.
To read more or access our algorithms and calculators, please log in or register.
